Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Toshihide Shima"'
Autor:
Hiroshi Ishiba, Yoshio Sumida, Yuya Seko, Saiyu Tanaka, Masato Yoneda, Hideyuki Hyogo, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki, Masashi Yoneda, Hirokazu Takahashi, Takashi Nakahara, Kojiro Mori, Kazuyuki Kanemasa, Keiji Shimada, Kento Imajo, Kanji Yamaguchi, Takumi Kawaguchi, Atsushi Nakajima, Kazuaki Chayama, Toshihide Shima, Kazuma Fujimoto, Takeshi Okanoue, Yoshito Itoh, the Japan Study Group of NAFLD
Publikováno v:
Hepatology Communications, Vol 5, Iss 4, Pp 559-572 (2021)
This study aimed to examine whether the diagnostic accuracy of four noninvasive tests (NITs) for detecting advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is maintained or is inferior to with or without the presence of type 2 diabetes.
Externí odkaz:
https://doaj.org/article/c943576b74404d24865e8598197f9809
Autor:
Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Hidenori Toyoda, Makoto Nakamuta, Koichi Takaguchi, Tsunamasa Watanabe, Atsushi Hiraoka, Haruki Uojima, Toru Ishikawa, Motoh Iwasa, Toshifumi Tada, Akito Nozaki, Makoto Chuma, Shinya Fukunishi, Akira Asai, Toru Asano, Chikara Ogawa, Hiroshi Abe, Naoki Hotta, Toshihide Shima, Etsuko Iio, Shigeru Mikami, Yoshihiko Tachi, Shinichi Fujioka, Hironao Okubo, Noritomo Shimada, Joji Tani, Isao Hidaka, Akio Moriya, Kunihiko Tsuji, Takehiro Akahane, Naoki Yamashita, Tomomi Okubo, Taeang Arai, Kiyoshi Morita, Kazuhito Kawata, Yasuhito Tanaka, Takeshi Okanoue, Shin Maeda, Takashi Kumada, Katsuhiko Iwakiri, KTK49 Liver Study Group
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 851-866 (2020)
Abstract Introduction Clinical trials of direct-acting antivirals for patients with decompensated cirrhosis have been conducted, but there is limited information on the medicinal applications in clinical settings. We aimed to evaluate the safety and
Externí odkaz:
https://doaj.org/article/55849d97b2c94d3998b61e259f39e8f7
Autor:
Keiichiro Okuda, Atsushi Umemura, Seita Kataoka, Kota Yano, Aya Takahashi, Shinya Okishio, Hiroyoshi Taketani, Yuya Seko, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Hayato Nakagawa, Yu Liu, Yasuhide Mitsumoto, Yoshihiro Kanbara, Toshihide Shima, Takeshi Okanoue, Yoshito Itoh
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. HCC cells consume large amounts of glutamine to survive, but can adapt to glutamine depletion in the presence of an exogenous asparagine. L-asparaginase (ASNase) converts
Externí odkaz:
https://doaj.org/article/51f700cc3d644c598a99a775e3d1e527
Autor:
Seita Kataoka, Atsushi Umemura, Keiichiro Okuda, Hiroyoshi Taketani, Yuya Seko, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Yoshihiro Kanbara, Jack L. Arbiser, Toshihide Shima, Takeshi Okanoue, Yoshito Itoh
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 24, p 13354 (2021)
Chronic liver injury may result in hepatic fibrosis, which can progress to cirrhosis and eventually liver failure. There are no drugs that are specifically approved for treating hepatic fibrosis. The natural product honokiol (HNK), a bioactive compou
Externí odkaz:
https://doaj.org/article/6d1de62a58cf4b15a1d6e4a2f0dbe52e
Autor:
Yoshio Sumida, Toshihide Shima, Yasuhide Mitsumoto, Takafumi Katayama, Atsushi Umemura, Kanji Yamaguchi, Yoshito Itoh, Masashi Yoneda, Takeshi Okanoue
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 12, p 4337 (2020)
Type 2 diabetes (T2D) is closely associated with nonalcoholic fatty liver disease (NAFLD). Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD, can lead to cirrhosis, hepatocellular carcinoma (HCC), and hepatic decompensation. Patients with T
Externí odkaz:
https://doaj.org/article/29c8d1c077ef4730a0f53ce20e52298b
Autor:
Takahisa Kawaguchi, Toshihide Shima, Masayuki Mizuno, Yasuhide Mitsumoto, Atsushi Umemura, Yoshihiro Kanbara, Saiyu Tanaka, Yoshio Sumida, Kohichiro Yasui, Meiko Takahashi, Keitaro Matsuo, Yoshito Itoh, Katsutoshi Tokushige, Etsuko Hashimoto, Kendo Kiyosawa, Masanori Kawaguchi, Hiroyuki Itoh, Hirofumi Uto, Yasuji Komorizono, Ken Shirabe, Shiro Takami, Toshinari Takamura, Miwa Kawanaka, Ryo Yamada, Fumihiko Matsuda, Takeshi Okanoue
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0185490 (2018)
The genetic factors affecting the natural history of nonalcoholic fatty liver disease (NAFLD), including the development of nonalcoholic steatohepatitis (NASH) and NASH-derived hepatocellular carcinoma (NASH-HCC), are still unknown. In the current st
Externí odkaz:
https://doaj.org/article/6b653d846bff4fc2b98baf37577fb9b0
Autor:
Takahisa Kawaguchi, Yoshio Sumida, Atsushi Umemura, Keitaro Matsuo, Meiko Takahashi, Toshinari Takamura, Kohichiroh Yasui, Toshiji Saibara, Etsuko Hashimoto, Miwa Kawanaka, Sumio Watanabe, Sumio Kawata, Yasuharu Imai, Miki Kokubo, Toshihide Shima, Hyohun Park, Hideo Tanaka, Kazuo Tajima, Ryo Yamada, Fumihiko Matsuda, Takeshi Okanoue, Japan Study Group of Nonalcoholic Fatty Liver Disease
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e38322 (2012)
Nonalcoholic fatty liver disease (NAFLD) includes a broad range of liver pathologies from simple steatosis to cirrhosis and fibrosis, in which a subtype accompanying hepatocyte degeneration and fibrosis is classified as nonalcoholic steatohepatitis (
Externí odkaz:
https://doaj.org/article/3d1e018bb8124f0f91fb19d321fff394
Autor:
Yuya, Seko, Hirokazu, Takahashi, Hidenori, Toyoda, Hideki, Hayashi, Kanji, Yamaguchi, Michihiro, Iwaki, Masato, Yoneda, Taeang, Arai, Toshihide, Shima, Hideki, Fujii, Asahiro, Morishita, Kazuhito, Kawata, Kengo, Tomita, Miwa, Kawanaka, Yuichi, Yoshida, Tadashi, Ikegami, Kazuo, Notsumata, Satoshi, Oeda, Yoshihiro, Kamada, Yoshio, Sumida, Hideaki, Fukushima, Eiji, Miyoshi, Shinichi, Aishima, Takeshi, Okanoue, Atsushi, Nakajima, Yoshito, Itoh
Publikováno v:
Hepatology Research. 53:312-321
The enhanced liver fibrosis (ELF) test is a noninvasive method for diagnosing hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). This multicenter cohort study aimed to evaluate the accuracy of the ELF test and compare it with
Autor:
Kanji, Yamaguchi, Toshihide, Shima, Yasuhide, Mitsumoto, Yuya, Seko, Atsushi, Umemura, Yoshito, Itoh, Atsushi, Nakajima, Shuichi, Kaneko, Kenichi, Harada, Timothy, Watkins, Takeshi, Okanoue
Publikováno v:
Hepatology International. 17:573-583
Fibro-Scope is an artificial intelligence/neural network system to determine the fibrosis stage in nonalcoholic steatohepatitis (NASH) using 12 parameters of the patient: age, sex, height, weight, waist circumference (WC), platelet count, and the lev
Autor:
Hidenori Toyoda, Satoshi Yasuda, Akio Moriya, Ei Itobayashi, Haruki Uojima, Tsunamasa Watanabe, Masanori Atsukawa, Taeang Arai, Toru Ishikawa, Shigeru Mikami, Atsushi Hiraoka, Kunihiko Tsuji, Tsunekazu Oikawa, Akihito Tsubota, Akito Nozaki, Makoto Chuma, Hiroshi Abe, Toshihide Shima, Takashi Kumada, Junko Tanaka
Publikováno v:
Journal of Infection and Chemotherapy. 28:1231-1234
With the increase in the number of patients with sustained virologic response (SVR) in whom hepatitis C virus (HCV) was eradicated by the anti-HCV therapy, there are now many individuals in whom serum HCV RNA is absent despite positive serum HCV anti